Literature DB >> 23884042

Impaired default network functional connectivity in autosomal dominant Alzheimer disease.

Jasmeer P Chhatwal1, Aaron P Schultz, Keith Johnson, Tammie L S Benzinger, Clifford Jack, Beau M Ances, Caroline A Sullivan, Stephen P Salloway, John M Ringman, Robert A Koeppe, Daniel S Marcus, Paul Thompson, Andrew J Saykin, Stephen Correia, Peter R Schofield, Christopher C Rowe, Nick C Fox, Adam M Brickman, Richard Mayeux, Eric McDade, Randall Bateman, Anne M Fagan, Allison M Goate, Chengjie Xiong, Virginia D Buckles, John C Morris, Reisa A Sperling.   

Abstract

OBJECTIVE: To investigate default mode network (DMN) functional connectivity MRI (fcMRI) in a large cross-sectional cohort of subjects from families harboring pathogenic presenilin-1 (PSEN1), presenilin-2 (PSEN2), and amyloid precursor protein (APP) mutations participating in the Dominantly Inherited Alzheimer Network.
METHODS: Eighty-three mutation carriers and 37 asymptomatic noncarriers from the same families underwent fMRI during resting state at 8 centers in the United States, United Kingdom, and Australia. Using group-independent component analysis, fcMRI was compared using mutation status and Clinical Dementia Rating to stratify groups, and related to each participant's estimated years from expected symptom onset (eYO).
RESULTS: We observed significantly decreased DMN fcMRI in mutation carriers with increasing Clinical Dementia Rating, most evident in the precuneus/posterior cingulate and parietal cortices (p < 0.001). Comparison of asymptomatic mutation carriers with noncarriers demonstrated decreased fcMRI in the precuneus/posterior cingulate (p = 0.014) and right parietal cortex (p = 0.0016). We observed a significant interaction between mutation carrier status and eYO, with decreases in DMN fcMRI observed as mutation carriers approached and surpassed their eYO.
CONCLUSION: Functional disruption of the DMN occurs early in the course of autosomal dominant Alzheimer disease, beginning before clinically evident symptoms, and worsening with increased impairment. These findings suggest that DMN fcMRI may prove useful as a biomarker across a wide spectrum of disease, and support the feasibility of DMN fcMRI as a secondary endpoint in upcoming multicenter clinical trials in Alzheimer disease.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23884042      PMCID: PMC3776464          DOI: 10.1212/WNL.0b013e3182a1aafe

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  38 in total

Review 1.  Mild cognitive impairment.

Authors:  Serge Gauthier; Barry Reisberg; Michael Zaudig; Ronald C Petersen; Karen Ritchie; Karl Broich; Sylvie Belleville; Henry Brodaty; David Bennett; Howard Chertkow; Jeffrey L Cummings; Mony de Leon; Howard Feldman; Mary Ganguli; Harald Hampel; Philip Scheltens; Mary C Tierney; Peter Whitehouse; Bengt Winblad
Journal:  Lancet       Date:  2006-04-15       Impact factor: 79.321

2.  When less means more: deactivations during encoding that predict subsequent memory.

Authors:  S M Daselaar; S E Prince; R Cabeza
Journal:  Neuroimage       Date:  2004-11       Impact factor: 6.556

3.  The human brain is intrinsically organized into dynamic, anticorrelated functional networks.

Authors:  Michael D Fox; Abraham Z Snyder; Justin L Vincent; Maurizio Corbetta; David C Van Essen; Marcus E Raichle
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-23       Impact factor: 11.205

4.  Neurodegenerative diseases target large-scale human brain networks.

Authors:  William W Seeley; Richard K Crawford; Juan Zhou; Bruce L Miller; Michael D Greicius
Journal:  Neuron       Date:  2009-04-16       Impact factor: 17.173

5.  Default mode network connectivity in stable vs progressive mild cognitive impairment.

Authors:  J R Petrella; F C Sheldon; S E Prince; V D Calhoun; P M Doraiswamy
Journal:  Neurology       Date:  2011-01-12       Impact factor: 9.910

Review 6.  Functional MRI of mnemonic networks across the spectrum of normal aging, mild cognitive impairment, and Alzheimer's disease.

Authors:  Jasmeer P Chhatwal; Reisa A Sperling
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

7.  Age and amyloid-related alterations in default network habituation to stimulus repetition.

Authors:  Patrizia Vannini; Trey Hedden; John A Becker; Caroline Sullivan; Deepti Putcha; Dorene Rentz; Keith A Johnson; Reisa A Sperling
Journal:  Neurobiol Aging       Date:  2011-02-18       Impact factor: 4.673

Review 8.  Biomarkers for early detection of Alzheimer pathology.

Authors:  C M Clark; C Davatzikos; A Borthakur; A Newberg; S Leight; V M-Y Lee; J Q Trojanowski
Journal:  Neurosignals       Date:  2007-12-05

9.  Brain imaging and fluid biomarker analysis in young adults at genetic risk for autosomal dominant Alzheimer's disease in the presenilin 1 E280A kindred: a case-control study.

Authors:  Eric M Reiman; Yakeel T Quiroz; Adam S Fleisher; Kewei Chen; Carlos Velez-Pardo; Marlene Jimenez-Del-Rio; Anne M Fagan; Aarti R Shah; Sergio Alvarez; Andrés Arbelaez; Margarita Giraldo; Natalia Acosta-Baena; Reisa A Sperling; Brad Dickerson; Chantal E Stern; Victoria Tirado; Claudia Munoz; Rebecca A Reiman; Matthew J Huentelman; Gene E Alexander; Jessica B S Langbaum; Kenneth S Kosik; Pierre N Tariot; Francisco Lopera
Journal:  Lancet Neurol       Date:  2012-11-06       Impact factor: 44.182

10.  Comparison of multi-subject ICA methods for analysis of fMRI data.

Authors:  Erik Barry Erhardt; Srinivas Rachakonda; Edward J Bedrick; Elena A Allen; Tülay Adali; Vince D Calhoun
Journal:  Hum Brain Mapp       Date:  2010-12-15       Impact factor: 5.038

View more
  79 in total

1.  Longitudinal cognitive and biomarker changes in dominantly inherited Alzheimer disease.

Authors:  Eric McDade; Guoqiao Wang; Brian A Gordon; Jason Hassenstab; Tammie L S Benzinger; Virginia Buckles; Anne M Fagan; David M Holtzman; Nigel J Cairns; Alison M Goate; Daniel S Marcus; John C Morris; Katrina Paumier; Chengjie Xiong; Ricardo Allegri; Sarah B Berman; William Klunk; James Noble; John Ringman; Bernardino Ghetti; Martin Farlow; Reisa A Sperling; Jasmeer Chhatwal; Stephen Salloway; Neill R Graff-Radford; Peter R Schofield; Colin Masters; Martin N Rossor; Nick C Fox; Johannes Levin; Mathias Jucker; Randall J Bateman
Journal:  Neurology       Date:  2018-09-14       Impact factor: 9.910

2.  Brain Imaging and Blood Biomarker Abnormalities in Children With Autosomal Dominant Alzheimer Disease: A Cross-Sectional Study.

Authors:  Yakeel T Quiroz; Aaron P Schultz; Kewei Chen; Hillary D Protas; Michael Brickhouse; Adam S Fleisher; Jessica B Langbaum; Pradeep Thiyyagura; Anne M Fagan; Aarti R Shah; Martha Muniz; Joseph F Arboleda-Velasquez; Claudia Munoz; Gloria Garcia; Natalia Acosta-Baena; Margarita Giraldo; Victoria Tirado; Dora L Ramírez; Pierre N Tariot; Bradford C Dickerson; Reisa A Sperling; Francisco Lopera; Eric M Reiman
Journal:  JAMA Neurol       Date:  2015-08       Impact factor: 18.302

3.  The INTUIT Study: Investigating Neuroinflammation Underlying Postoperative Cognitive Dysfunction.

Authors:  Miles Berger; Deborah Oyeyemi; Mobolaji O Olurinde; Heather E Whitson; Kent J Weinhold; Marty G Woldorff; Lewis A Lipsitz; Eugene Moretti; Charles M Giattino; Kenneth C Roberts; Junhong Zhou; Thomas Bunning; Michael Ferrandino; Randall P Scheri; Mary Cooter; Cliburn Chan; Roberto Cabeza; Jeffrey N Browndyke; David M Murdoch; Michael J Devinney; Leslie M Shaw; Harvey Jay Cohen; Joseph P Mathew
Journal:  J Am Geriatr Soc       Date:  2019-01-23       Impact factor: 5.562

4.  Neuroimaging and Dementia.

Authors:  Başar Bilgiç
Journal:  Noro Psikiyatr Ars       Date:  2018-03-19       Impact factor: 1.339

5.  Phases of Hyperconnectivity and Hypoconnectivity in the Default Mode and Salience Networks Track with Amyloid and Tau in Clinically Normal Individuals.

Authors:  Aaron P Schultz; Jasmeer P Chhatwal; Trey Hedden; Elizabeth C Mormino; Bernard J Hanseeuw; Jorge Sepulcre; Willem Huijbers; Molly LaPoint; Rachel F Buckley; Keith A Johnson; Reisa A Sperling
Journal:  J Neurosci       Date:  2017-03-17       Impact factor: 6.167

6.  Different Hippocampus Functional Connectivity Patterns in Healthy Young Adults with Mutations of APP/Presenilin-1/2 and APOEε4.

Authors:  Li Juan Zheng; Yun Yan Su; Yun Fei Wang; U Joseph Schoepf; Akos Varga-Szemes; Jonathan Pannell; Xue Liang; Gang Zheng; Guang Ming Lu; Gui Fen Yang; Long Jiang Zhang
Journal:  Mol Neurobiol       Date:  2017-05-13       Impact factor: 5.590

7.  Functional connectivity in autosomal dominant and late-onset Alzheimer disease.

Authors:  Jewell B Thomas; Matthew R Brier; Randall J Bateman; Abraham Z Snyder; Tammie L Benzinger; Chengjie Xiong; Marcus Raichle; David M Holtzman; Reisa A Sperling; Richard Mayeux; Bernardino Ghetti; John M Ringman; Stephen Salloway; Eric McDade; Martin N Rossor; Sebastien Ourselin; Peter R Schofield; Colin L Masters; Ralph N Martins; Michael W Weiner; Paul M Thompson; Nick C Fox; Robert A Koeppe; Clifford R Jack; Chester A Mathis; Angela Oliver; Tyler M Blazey; Krista Moulder; Virginia Buckles; Russ Hornbeck; Jasmeer Chhatwal; Aaron P Schultz; Alison M Goate; Anne M Fagan; Nigel J Cairns; Daniel S Marcus; John C Morris; Beau M Ances
Journal:  JAMA Neurol       Date:  2014-09       Impact factor: 18.302

Review 8.  Disruption of resting functional connectivity in Alzheimer's patients and at-risk subjects.

Authors:  Lenka Krajcovicova; Radek Marecek; Michal Mikl; Irena Rektorova
Journal:  Curr Neurol Neurosci Rep       Date:  2014-10       Impact factor: 5.081

Review 9.  Network dysfunction in Alzheimer's disease: refining the disconnection hypothesis.

Authors:  Matthew R Brier; Jewell B Thomas; Beau M Ances
Journal:  Brain Connect       Date:  2014-06

Review 10.  Cerebral blood flow regulation and neurovascular dysfunction in Alzheimer disease.

Authors:  Kassandra Kisler; Amy R Nelson; Axel Montagne; Berislav V Zlokovic
Journal:  Nat Rev Neurosci       Date:  2017-05-18       Impact factor: 34.870

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.